Hajdu-Cheney Syndrome is a very rare genetic condition. It affects bone growth and can cause bones in the hands and feet to break down, leading to bone loss and skull changes. It's usually diagnosed in childhood.
Every report comes from a Lived member, sent anonymously.
Have you tried Zoledronic Acid for Hajdu-Cheney Syndrome?
Hajdu-Cheney syndrome is a rare genetic disorder of bone development and bone upkeep. Its hallmark is acroosteolysis, a gradual loss of bone from the tips of the fingers and, less often, the toes. The fingertips can look short and rounded and may shorten further over time, which can make fine tasks such as picking up small objects harder. Most people also develop osteoporosis, meaning bones that are thin, brittle and prone to breaking, including the bones of the spine. The syndrome also changes the skull and face. The skull is often long from front to back with a bump at the back of the head, and facial features tend to become more distinctive with age. The most serious problem involves the base of the skull, which can soften and flatten. This can let the top of the spine push upward into the lower brain, a complication called basilar invagination. Teeth, hearing, the voice, joints, the heart and the kidneys can be affected as well. Features differ widely from person to person, even within one family, and many are not present at birth but appear during childhood or later.
Hajdu-Cheney syndrome is caused by a change (variant) in the NOTCH2 gene. This gene makes a receptor involved in building bone and in remodeling, the lifelong process of removing old bone and replacing it. The variants behind this syndrome make the receptor resistant to normal breakdown, so its signaling stays switched on too strongly. How that overactivity leads to each feature is not fully understood. The condition is autosomal dominant: one altered copy of the gene is enough to cause it, and a parent who has it has a 50% chance of passing it to each child. Many people, though, are the first in their family to have it, because the variant arose new (de novo) in an egg, a sperm or very early in development. Fewer than 100 people with the syndrome have been described in medical reports.
The diagnosis is usually first suspected from a combination of features: short fingertips, fractures or low bone density at a young age, and characteristic changes in the face and skull. X-rays support the suspicion. They can show bone loss at the ends of the fingers and toes, skull sutures that stay open longer than usual, small extra bones in those sutures (wormian bones), a flattened skull base, and thinning or collapsed vertebrae in the spine. Genetic testing of the NOTCH2 gene confirms the diagnosis. This matters because other conditions can look similar. Bone loss in the fingertips can also come from scleroderma, other autoimmune diseases, injury or nerve damage, and in early childhood the facial features can be mistaken for Noonan syndrome. A confirmed diagnosis also guides which follow-up checks are needed. Once it is confirmed, clinicians usually look for the syndrome's other effects: a bone density scan, magnetic resonance imaging (MRI, a detailed scan that uses magnets rather than X-rays) of the area where the skull meets the neck, and checks of hearing, teeth, heart and kidneys. In families where a parent has a known NOTCH2 variant, testing during pregnancy is possible.
No treatment corrects the underlying gene change, and because the syndrome is so rare there are no formal treatment guidelines. Care focuses on preventing and managing each complication, usually through a team that may include an endocrinologist or bone specialist, an orthopedic or spine surgeon, a neurosurgeon, a dentist, and heart, kidney and hearing specialists as needed. Osteoporosis medicines are often tried. These include bisphosphonates such as alendronate, which slow the breakdown of bone, and, in some individual cases, bone-building medicines such as teriparatide or romosozumab. Some people have had improvements in bone density, but there are no controlled studies, and it has not been shown that any of these medicines prevents fractures in this syndrome. The choice is made case by case with a specialist. Because teeth and jaw bone are already fragile in this condition, and bone-slowing medicines such as bisphosphonates and denosumab carry a small risk of jaw bone damage after dental surgery, the dentist and the prescriber should plan dental work and bone treatment together. Surgery is used for specific problems. When basilar invagination compresses the brainstem, neurosurgeons may relieve the pressure and stabilize the junction of the skull and neck; a shunt can drain fluid that builds up in the brain (hydrocephalus). Spine surgery, fracture care and dental treatment address other problems as they arise.
Hajdu-Cheney syndrome changes over a lifetime. Bone loss in the fingertips, osteoporosis and spinal changes generally progress with age, and many people are shorter than average, partly because vertebrae compress. Fractures, spinal curvature and finger changes can make walking, hand use and some everyday tasks harder over time, and some people come to need help with daily activities. Early tooth loss is common, so dental care is a long-term part of life. Some children have delayed development, but the delays are usually mild. Outlook varies widely and depends mostly on which organs are involved. Because so few people have been studied, it is not known how the syndrome affects lifespan overall. The greatest danger is progressive basilar invagination, which affects roughly half of reported patients; in severe cases it can compress the brainstem and interfere with breathing and swallowing, and it has caused deaths. For this reason, regular follow-up commonly includes MRI of the skull and neck junction, more often during growth, alongside neurological checks, bone density testing, spine monitoring and dental, hearing, heart and kidney reviews as needed.
Arrange an evaluation with a genetics or bone specialist if fingertip bone loss, early or repeated fractures, or the skull and facial features described here are present, or if a close relative has the syndrome. Once diagnosed, keep scheduled imaging and specialist visits even when nothing feels different, since skull base changes can progress quietly. Contact the care team promptly about new trouble swallowing, hoarseness, noisy breathing, breathing problems during sleep, a spinal curve that seems to be worsening quickly, or a new fracture. These can be early signs that the skull base is pressing on the brainstem and may call for earlier imaging. Call 911 for severe or rapidly worsening difficulty breathing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hajdu-Cheney Syndrome is like, what's helped you, or ask the community a question.